Cardiac Pacemakers
KEYWORDS: class, block, evidence, heart, opinion, patients, ventricular, pacemaker, pacing, sinus, bradycardia, symptoms, rate, iii, symptomatic

girdle and unlikely to AV block, or HV (eg, myotonic Emery Dreifuss recur (eg, due interval of ≥ 70 dystrophy) if muscular to medication milliseconds in life expectancy dystrophies) toxicity or patients with > 1 year and life Lyme disease neuromuscular expectancy > 1 diseases or occurring year associated with asymptomatica conduction First-degree or lly during abnormalities second-degree transient (eg, myotonic type I AV block increases in dystrophy) with symptoms vagal tone) regardless of that are clearly symptoms attributable to the AV block Symptomatic bradycardia in patients with atrial fibrillation Symptomatic AV block due to essential medications which cannot be discontinued Tachyarrhythm Sustained, High-risk Prevention of Frequent or pause- patients with symptomatic, complex 3/13 Class IIb Class I Class IIa Class III (Less Well (Evidence or (Evidence or (Not Arrhythmia Supported Opinion Opinion In Indicated or by Evidence Supports)* Favor)* Harmful)* or Opinion)* ias‡ dependent VT congenital long recurrent atrial ventricular (including QT syndrome fibrillation ectopy without torsades de refractory to sustained VT Symptomatic pointe VT) medications when long QT recurrent SVT when sinus syndrome is reproducibly node absent terminated by dysfunction pacing when Torsades de coexists ablation and/or pointes VT with medications reversible fail (except causes when there is
